Earnings Call · Q2 FY2023·2023-08-09

Q2 23EPS -18.10%·Rev n/aQ1 23EPS -16.13%·Rev n/aQ4 22EPS -18.18%·Rev n/aQ3 22EPS +2.94%·Rev n/a⚠ consensus missing

Bionano Genomics, Inc. BNGO

David Holmes — Investor Relations

Erik Holmlin — Chief Executive Officer

Chris Stewart — Chief Financial Officer

−3.4%1d on move date−3.4% vs SPY3d−16.6%5d−25.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BNGO calls or request research access.

More BNGO calls Browse calls Request research access